Human Immunodeficiency Virus Treatment and Prevention for Pregnant and Postpartum Women in Global Settings
Review and description of current HIV prevention, specifically PMTCT, strategies in pregnant and breastfeeding women, including ART during pregnancy/breastfeeding and lifelong ART for women living with HIV, PrEP use during pregnancy/breastfeeding for women not living with HIV, and integrating other HIV prevention services with PrEP. However, more work needs to be done in implementing evidence-based practices (as listed above) in high-burden, low-resource settings. Possible strategies include integration of HIV testing with routine antenatal care, differentiated care models, and postnatal adherence clubs.
Resource Details
- Study Type
- Review
- Year
- 2022
- Population
- Pregnant & Postpartum Women
- Author
- Saidi F, Chi BH
- Source
- Obstet Gynecol Clin N Am
More Publications & Resources
Standard Operating Procedure for Injectable Lenacapavir as Pre-exposure Prophylaxis
Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP
Site/Facility Readiness Assessment Tool to Support Lenacapavir for HIV Prevention Introduction
Rapid Landscape Analysis of National Vertical Transmission Policies for Inclusion of PrEP for Pregnant and Breastfeeding People
Tools for Active Safety Surveillance of Maternal and Infant Health Outcomes for Pregnant and Breastfeeding Users of Oral PrEP and PrEP Ring
Long-Acting Injectable Antiretroviral Drugs for Pregnant and Breastfeeding Women: Current Advances, Challenges, and Future Directions
Assessment of Facility Readiness for PrEP Provision in Antenatal and Postnatal Care Services
Oral PrEP for PBFP Training Package
Key Considerations for Integration of PrEP for Pregnant and Breastfeeding People into National Prevention of Vertical Transmission Polices
No results found.